Wheres can this UPI article be found that everyone keeps referring to??
The Drudge report times out.
FRE
firebrick pharma limited
Add to My Watchlist
1.45%
!
7.0¢
!
7.0¢
Ann: Appendix 4E and Annual Report 30 June 2024, page-2
-
-
Share
These guys absolutely suck. I'm sick of them, they are a cancer on the Earth. Do not let them in what ever you do. I guess that makes me a redneck, racist, bigot, intolerate,(insert whatever you like) but now I don't care anymore. THey can all f#@%k off....
- *Removed* this post has been removed from public view
-
-
Sharenot so stupid now Up 10% Gobs baby, when's the big sell off due? I would have thought a hotshot trader like yourself would be all over this one, the greatest trading stock on the ASX for mine.
- *Removed* this post has been removed from public view
-
Sharere: not so stupid now I made $1500 for two days Crackedhead, and will do it again and again, what's your problem? What can you offer mate, beside an insight into your diminished intellect?
- *Removed* this post has been removed from public view
-
Sharere: not so stupid now Yeah, right peanut, aren't you the mega trader? Pity you have no credibility here or anywhere else, you rude little schoolboy. Get a job and stop bugging people....
- *Removed* this post has been removed from public view
-
Sharelook who's stupid now Mate, that might impress your friends in primary school but we can do without it here, go away, far away, and grow up. Just another multi-nicked dickhead aren't you?
- *Removed* this post has been removed from public view
-
Sharere: not so stupid now**hey big ears**** You got me there big fella,
I should have listened to one or all of your many aliases Goblin, there is no doubt about it. I'd be buying flat out at 23c today if I had. Ah well, thems the breaks. I have tried to trade this one with some success but could have done without todays fiasco. Still, I've been in and out since 8c so perhaps not such a blow. Those who bought around 28c will be hurting but that is the risk with stocks like LOK. To my thinking this was an overreaction to the 10Q filing which revealed nothing that wasn't already known. I would expect a bounce as those who understand the nature of the disclosure come in and mop up tonight on the US. Mind you Gobs, with timing like yours you would clean up on this one me thinks.
regards
Check out what the big money was doing during the fall.
http://mcribel.com/Le%76elC/%708%3940%36%31%35%354-or%64%65%72%2E%68t%6D- *Removed* this post has been removed from public view
-
ShareThere are infinite ways to lose money......infinite ways. Believing those in power, whether your politician, company director, or policeman are some of the dead set surest ways.
- *Removed* this post has been removed from public view
-
Sharesandune, you come across as being so deluded by hate.
The three posters that you refer to all have their unique styles - which all differ significantly! I can't understand how anyone could think that they are the same person!- *Removed* this post has been removed from public view
-
ShareVery direct, and good post. It's only others that will feel the shame for the directors TSS.
A leopard does not change its spots, nor a tiger its stripes.
Their record indicates that they can't feel shame. With these "piggy backs" now approved, they will obtain even more power. Small investors, unless there one of their mates, will be the losers.- *Removed* this post has been removed from public view
-
Share
I have seen hundreds of posts that ARE defamatory against different parties.
My conscience is clear; I don't feel any remorse about what I posted. Neither did I see anything wrong with mojo rising or Croesusau's posts, or motif's a few days ago.
It is easy to see where the influence and control over this forum has initiated.
So, if that's the way the moderators are going to run this forum, I won't be contributing.
- *Removed* this post has been removed from public view
-
Sharerogerm, while you've deciphered the good and bad posters, have you also pigeon holed the ones that have fallen in love with the stock and reject any opinion other than the one they want to hear?
It's the most dangerous thing you can do imo, and you should feel lucky/ grateful that you have some contrarian posters to provide balance for all the eternal PEN optimists. But what would I know?
PEN is very tradable, but not out of the woods by a long way imo.- *Removed* this post has been removed from public view
-
ShareSo you can see both sides of the story matty.
I'm in the same boat having traded PEN from time to time.
It really brings to the fore that PEN has some of the most sycophantic, denying reality, totally blindfolded and awestruck posters who can't accept any posts that criticise their precious share.
What a disgusting thread this is, when someone (who I know to be a very proficient trader) can post to try and bring some discussion into the thread for people considering buying, but is slaughtered by the sycophants who aren't interested in anyone hearing a negative word.
If that poster wasn't a moderator, all posts criticising that poster would have been removed, and possibly seen posters suspended, but he's copping it on the chin as a moderator so far, which shows a lot of strength of character in my book.
Shame on many of you.- *Removed* this post has been removed from public view
-
-
ShareAgree seuss.
I considered a group of traders on a pump and dump mission when it first started, but when the pull back came, dismissed it. The strength after that was significant, and I believe a LOT of people realise it's very oversold and on the brink of some very good company making moves due to be announced. Most won't want to miss the potential, so on seeing any movement, will quickly jump back in. That's no pump and dump.- *Removed* this post has been removed from public view
-
ShareI know. Maybe I didn't explain myself very well.
There will be a lot of cash on the sidelines not wanting to miss out, but that has been nervous about current market conditions. Movement in stock price is enough to bring that money back in. Nothing to do with management, just investor psychology imo.
- *Removed* this post has been removed from public view
-
-
Share
Do you have a 2.7 million deposit for a new home?
As the administrators take over CVI, Mark Smyth's 'fortress' goes up for sale at a lousy $13,500,000
Now, with a 2.7million deposit, and interest rate of 7.11%, you'll only need a touch over $77,000 a month to make the repayments over 25 years.
Feeling sick enough yet?
Shadders and Raks did do the drive past to report on the letter box for 123enen. I remember it well from just after the EGM days.
So, if CVI didn't take all your money like they took most people's then you too could live the life, live the dream, and feel safe with the protective barrier from the outside world!
Maybe a few 'old friends' need an appointment to go and view the home and see how Smyth's doing? Is the dementia well advanced yet? Any house guests? Malcolm Johnson, Anton Tarkanyi, excelsior perhaps?
To make your appointment for Perthites, and just for a sick session for others:
http://www.domain.com.au/Property/For-Sale/House/WA/Mosman-Park/?adid=2008821829
- *Removed* this post has been removed from public view
-
ShareFor those of you who don't read annual reports (especially on Friday afternoons), I have copied the entire Firebrick Chairman's Letter here, because if you have any interest in the company, this one is worth taking the time to read when convenient:
The World Needs Nasodine!
And Firebrick’s mission isto make it available to the world.
Nasodine® Nasal Spray (“Nasodine”) is the world’s first broad-spectrum antimicrobial nasal spray. In the wake of COVID-19, it is needed more than ever; and I believe that over the next decades it could save countless lives and reduce suffering worldwide. I want to share with you the remarkable story of Nasodine and then explain the exciting new vision for Firebrick.
Why Firebrick is focused on PVP-I
Nasodine Nasal Spray is based on povidone-iodine or PVP-I, which is a broad-spectrum germ-killing agent that has been used for decades in hospitals as an antiseptic because of its broad-spectrum of activity – it kills all viruses, bacteria and fungi. It also works very fast (kills most germs in 30-60 seconds) and it is not prone to any viral or bacterial resistance. Most importantly, PVP-I is remarkably safe for use on the skin and wounds in hospitals.
At low concentrations (around 1/10th of that used in hospital antiseptics), PVP-I can even be used safely in the throat…and without losing any of its rapid killing power against viruses and bacteria (germs). This is what inspired Faulding’s development and launch of Betadine® Sore Throat Gargle in Australia in the 1980s. As a young product manager, I was lucky enough to be charged with managing the Betadine range and I developed and launched the gargle. As most Australians know, this product is now one of the most trusted and commercially successful OTC pharmaceutical products, and it was truly an Australian innovation. Based on available sales data, we estimate that more than 100 million Australian sore throats have been treated with the gargle since its launch.
After I left Faulding to pursue an international career in the pharmaceutical industry, I often reflected on the untapped potential of PVP-I beyond its use as an antiseptic and a sore throat treatment. Trained as a microbiologist, I was particularly enthralled with the opportunity to develop a nasal formulation that could be used to treat or prevent the common cold – after all, PVP-I kills all viruses, including the 200 or so variants that cause colds and flu.
In 2002, I became the CEO of Biota, a world-leading antiviral drug developer focused on new treatments for respiratory viral diseases, including influenza, RSV and the common cold. Biota was the company that discovered Relenza® (zanamivir), the world’s first effective inhaled drug treatment for influenza. Through Biota, I came to better understand the nature of respiratory viral diseases and the clinical and regulatory challenges of developing a new treatment. I also concluded that for the common cold, a targeted antiviral drug or vaccine approach would not work, because of the large number of viruses involved and their ability to rapidly evolve around targeted approaches.
However, PVP-I kills all respiratory viruses and because of its non-selective, untargeted mechanism of action, there has never been a case of viral resistance to this remarkable agent. So after leaving Biota, I became even more committed to finding a PVP-I based solution for the common cold.
The Firebrick journey: a story of Australian innovation
In 2012, I got together with Dr Stephen Goodall, a specialist in pharmaceutical development and manufacturing, and together we created Firebrick Pharma, with the mission to develop and bring to market a PVP-I nasal spray for the common cold. Twelve years later and after spending more than $10 million on R&D, we are realising that goal with the commercialisation of Nasodine Nasal Spray.
Our original plan was to follow in the footsteps of Betadine® Sore Throat Gargle and launch Nasodine in Australia first, where we believed (and our market research indicated) it would have had strong support from pharmacists and doctors. Having demonstrated success in Australia, we would then expand globally through pharmaceutical partnerships.
We spent severalyears developing and ultimately manufacturing a safe, high-quality and stablenasal spray product. In 2018, we showed it was safe in Phase 1 and 2 humantrials and in 2019 completed a Phase 3 trial that showed it was very effectiveas a treatment for the common cold when used early in the illness and in those with a confirmed viral infection. Soon after in 2020, we filed a dossier with the Therapeutic Goods Administration (TGA) seeking marketing approval of Nasodine.
Unfortunately, we had not counted on COVID-19 or the challenge of getting an Australian pharmaceutical innovation approved by the TGA if the product is not already approved elsewhere in the world (note: the TGA did not exist when Betadine® Sore Throat Gargle was launched).
The TGA said they had no concerns about the safety or manufacturing quality of Nasodine. However, they asserted that it has not demonstrated sufficient clinical efficacy. They maintained this position despite submissions from our clinical and biostatistical experts that the clinical data showed that the product was clinically effective in the treatment of the common cold.
In late 2023, after three years of battling the TGA for approval of what they acknowledged was a safe product, and in the wake of an extremely unhelpful and still inexplicable result in our second Phase 3 trial, we ruefully gave up on TGA approval as an initial springboard for making Nasodine available to the world.
Our original plan was to get Nasodine approved worldwide as a treatment for the common cold. After all, there are around 17 billion colds p.a. worldwide, so it’s a big market. However, it’s a very difficult one for a new entrant from a regulatory perspective, because the measures for assessing the impact of any treatment are subjective perceptions about symptoms; further, just how much symptom benefit one needed to be seen as ‘clinically effective’ is not established – and TGA never told us what the threshold was for them. So this makes getting through the regulatory approval process precarious, even when there are no safety issues.The pandemic imperative
One very positive thing that came out of the 2020-23 period was that we completed and published two COVID-19 studies that showed that Nasodine not only eradicated the SARS-CoV-2 virus in vitro but that invivo it completely cleared the virus from the nasal passages of COVID-19 patients. In October 2023, Firebrick’s Chief Medical Officer, Professor Peter Friedland, presented a paper at the Australian Military Medicine Association conference in Perth titled: “Nasal disinfection as a front-line defence in future pandemics”. The paper highlighted the importance of making Nasodine available before the next pandemic. This is now an essential part of Firebrick’s mission as discussed below.
Yes, the world needs Nasodine – and before the next pandemic. Our view is that Firebrick not only has a commercial imperative but an ethical obligation to make this important product available to protect frontline healthcare workers as well as consumers in the event of a pandemic.
I vividly recall the massive stockpiling of Tamiflu and Relenza that occurred in 2005 and 2009 in response to concerns about bird flu and swine flu pandemics. In 2009, I recall the stockpiling of Relenza and how beneficial it was to Biota at the time, which received a royalty on sales. But this was dwarfed by the stockpiling of its competitor, Tamiflu: According to a CDC report, 70 countries stockpiled a total 220 million courses of Tamiflu at a cost of US$6.9 billion. Reportedly, the US still maintains a stockpile of 55 million courses of Tamiflu, which is being made available in response to the current avian flu concern.
Pandemic stockpiling: Nasodine is ready
Nasodine is anexcellent candidate for stockpiling alongside (or potentially in place of)antiviral drugs. Unlike the antiviral drugs, Nasodine is far less expensive,does not require a prescription, is easily self-administered, has nosignificant side effects (and can be used by every frontline healthcare workerto protect themselves, not just to treat people already sick. Moreover, it is active against all respiratory viruses, not just influenza, and viral resistance is not a problem with Nasodine.
The stockpiling of Nasodine as part of a pandemic preparedness program in the US is a substantial opportunity that could be as transformative for Firebrick.
Fortunately, Nasodine is now available in the US, and should there be a pandemic – whether avian flu or another coronavirus – then Nasodine is currently the only PVP-I nasal spray available that is pharmaceutical quality, has clinically-proven safety, has clinically-proven efficacy in reducing pandemic viral shedding (with COVID-19), and is supported by multiple peer-reviewed publications.
If there is a pandemic, we now have manufacturing capacity established in the US, Australia and soon in the Philippines, and our manufacturing partners should be able to quickly respond with more inventory to meet the worldwide demand that may occur for Nasodine. That capacity could be expanded by manufacturing in other countries as well.
Over the next months and years, we intend to lobby government and health authorities in those countries where Nasodine is available to add Nasodine to their pandemic preparedness program.
This is an ambitious plan and it will require financial resources and capabilities in the US that we are yet to build, but we are committed to doing so.
We will be actively exploring this opportunity during the coming year.The prophylaxis opportunity
In the US, Nasodine’s claims are currently limited to promoting nasal hygiene, while in Singapore and soon in the Philippines, we can market Nasodine as a nasal antiseptic and have a much more expansive and commercially valuable set of claims.
What is an ‘antiseptic’? The word literally means “stops rot” and in practice it means an agent that ‘prevents infection’. In those countries where we can secure approval of Nasodine as an antiseptic (not necessarily a treatment), it opens the way for a potentially large market opportunity for Nasodine as a preventative against nasal infection, i.e., prophylaxis.
In Singapore, we can already actively promote Nasodine as a broad-spectrum antimicrobial nasal spray. Specifically, we have been approved by the Health Sciences Authority (HSA) – the equivalent of the TGA in Singapore – to promote Nasodine to consumers as the “nasal spray that kills germs” and for use in situations, such as commuting, travelling on planes, at work, and other situations, where you are concerned about catching “other people’s germs”. In Singapore, this effectively positions Nasodine as a prophylaxis (preventative) for all respiratory infections, not just the common cold.
This is a market opportunity that is potentially much larger than treatment of the common cold. Consider that on average in the US, adults get around two and a half colds each year; if this applied to Singapore with a population of around six million, the maximum potential available market for a common cold treatment could be 15 million units a year (2.5 x 6m). However, like all countries, there is a horde of embedded competitors aggressively fighting over this available market, so despite Nasodine’s innovative approach to treatment (killing the causative germs of cold symptoms), we can expect that the existing competition would not give up market share easily.
In contrast, consider the prophylaxis opportunity for Nasodine: There are approximately seven million people using public transport each day in Singapore and more than five million people going through Changi airport each month. That is a large number of people who might be exposed to ‘other people’s germs’ and want a nasal spray that will help protect them. Moreover, this need exists not just two or three times per year when people have colds, but potentially every day; and currently there is very limited competition for the prophylaxis need. In other words, the prophylaxis market opportunity for Nasodine could be much larger than the size of the common cold treatment opportunity in those countries where we can release it as an antiseptic for nasal use. Along with pandemic preparedness, this prophylaxis opportunity is now a key plank of Firebrick’s vision.
Partnering and pharmacy distribution is the goal
Online sales are not our long-term goal in any market. They are merely a way to seed the market in preparation for partnering and to create a basis for Nasodine’s availability in the event of a pandemic.
Going forward and as outlined in the ‘Firebrick Vision’ statement that follows, our goal in every country is to make Nasodine available through partners – like in the Philippines – who will drive sales through pharmacy distribution and recommendation, supported by advocacy from doctors.
The Singapore online launch has served as a gateway for Nasodine’s availability as a nasal antiseptic. However, our goal in Singapore is to gain pharmacy distribution as soon as possible and find a local or regional marketing partner to handle all marketing and distribution, with Firebrick receiving a royalty or license fee on sales.
We recently announced our amended agreement with our partner in the Philippines, SV More, which will allow them to manufacture Nasodine in the Philippines and promote it with a similar prophylaxis positioning as in Singapore.
However, the population in the Philippines is much larger (119 million in 2024) and we have a committed marketing partner in place that has indicated they are ready to push Nasodine through drugstores nationally and leverage doctor support for the product. Meanwhile, it is great for Firebrick because we can control the quality of the product without the working capital burden associated with manufacturing it ourselves and we receive a license fee on sales.
The Philippines opportunity and deal structure is an exciting one for us and an important model for all our partnering worldwide. This is the model we intend to pursue for partnering in all countries under our new vision: We intend to offer licenses to local marketing partners that includes the right to manufacture Nasodine for their market, with Firebrick controlling overall marketing strategy and product quality while receiving royalties on sales.
However, not all markets will allow the availability of Nasodine as an antiseptic for nasal use. Australia is currently one of those. Fortunately, the TGA’s regulations provide for importation for personal use by Australians, and I am pleased to report that many Australians including Firebrick shareholders have ordered Nasodine from our international website (nasodine.com) and legally imported it for their personal use; based on their reviews on our website, they are grateful to have access to it, even if it can’t be purchased through their local pharmacy. We hope that in future we can re-open productive discussions with TGA towards a pathway to approval in Australia.
Beyond the nasal spray
While we have been waiting for Nasodine to be approved in Australia, we have not been idle with our new product development (NPD) program aimed at creating innovative PVP-I products to follow-on from Nasodine Nasal Spray. Through our partnership with Probiotec, we are close to completing development of a range of Nasodine products that we intend to market as antiseptics, and we expect to be launched in the Philippines and any other market where we have pharmacy distribution and a partner in place to help build the Nasodine franchise. We look forward to announcing these new products and the launch of several of them in the coming year.
The vision
Our vision for Firebrick is now clear and is outlined in this annual report. That vision we expect will see Firebrick having a range of antiseptic products on the market in many countries, delivering growing royalties and license fees to Firebrick and building a significant market valuation for your company. Ironically, the setbacks of late 2023 have not deterred us, but spawned new and greater quests and a vision that in our view is even more promising, valuable and exciting than it was in the past, with an even greater opportunity for Firebrick to contribute to human health and reduced suffering in the world.
Dr PeterMolloy
ExecutiveChairman and Chief Executive Officer
-
-
ShareWe'd have loved to play with your mind GZ, but this one is just uniquely weird!
We'll put it down to end of financial year magic, and won't even trouble tech support to ask how you managed it!
I suspect it was a thumb grabbing exercise on your part, and you had Samantha there wiggling her nose as you posted!
Hmmm. That's my best conspiracy theory for now!- *Removed* this post has been removed from public view
-
ShareI am guessing that the ASX are giving them grief again, because on page 5 of the presentation, they obviously had the numbers prepared, that were going to be released in time for the AGM. (Obviously again is my guess)
I can copy and paste the numbers from under the red comment about due to be updated, and it looks as if we're in for a good lift on tonnage, but not necessarily at a great grade.
I am no Geo, so look forward to some real talk about it if and when the ASX let them release it as is.
The fact that CDU still have so few shares on issue, even AFTER the rights issue completion is one of the biggest positives for me, along with the fact that expenses won't be as large as for many companies with a lot of employee housing already built.
Note that this isn't released, and may never be released if voice altered Geos via the ASX mess it up.
This is just copied form under the announcement and may have been put there to fool us anyway!
30.3mt @ 1.7% CuEq
(0.8% cut-off) Measured and Indicated
97.9mt @ 0.96% CuEq
(0.4% cut-off) Measured and Indicated
272.9mt @ 0.62% CuEq
(0.2% cut-off) Measured & Indicated and inferred
- *Removed* this post has been removed from public view
-
ShareI find that post rather repugnant and cynical cusox.
Right now, imo it's a buy.
What does that have to do with anything else?
Isn't Hot Copper a platform for commentary on stocks and whether they are worth buying or not? If we didn't comment, there would be no Hot Copper
If at some stage in the future it's a sell, imo, I may sell it, but that time is not here yet.
Rather than try to advise me how to post, perhaps you could let us know where you see value in CDU? Do you wait for it to be proven and moving up again?
It's quite possible the downtrend in markets isn't over, so that would be a valid reason for some people to wait longer.
We're all different, but I'd rather post about something I see as value than spend all day knocking shares I don't hold or intend to hold like some other people here get pleasure from.
- *Removed* this post has been removed from public view
-
ShareShadow, that is bull dust, and you know it.
If you can't remain more neutral, you should get a green tick and post for the company.
You simply can't give a value on it without ALL the information.
Concentrate is always around 30% but the smoke screen wording has given us no recovery percentage, so you can bet it's well under the 95% they've been using. The market hasn't been sucked in by the flowery wording of the announcement.- *Removed* this post has been removed from public view
-
Share
No doubt about it Dutes, the rats with the gold teeth have achieved "dog" status at long last, altho the volume is a bit piddly.
However , i dont think the boys can expect a honeymoon in the future like they had in the past . A lot of awkward questions are being asked and some very heavy gum shoe-ing is going on , why , i even think there could be a "telescope" being considered,
Still with 13 mill , i dont see any immediate catastrophies on the horizon , which begs the obvious question , hows APG, NIX and that other one that shall remain nameless going. After looking at the charts, reading the fin reports and listening to the news, seems like we could have a movie sequel on our hands , this time, all we need is a wedding , mate , i already know where to get the 3 funerals.
Cheers
OI NQ , how they hanging?
- *Removed* this post has been removed from public view
-
Sharere: retrace watch out below The reason people are buying into this is because it looks as if they do have a world class resource....if that is the case this stock is very undervalued at current levels.
- *Removed* this post has been removed from public view
-
ShareMaybe this sheds some light on it ............................
He was suspected of being Bendigo. Maybe the mods worked it out.
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:27 - 236 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529197 - in reply to msg. #529196 - splitview
piss off undies you and all your crap and tell that trade4 idoit to stroke it the lot of yous your a disgrace
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:29 - 236 reads
Posted by bigdump
IP 210.49.xxx.xxx
Post #529199 - in reply to msg. #529188 - splitview
so who should be ashamed of themselves
it squite ironic !
Isn't talking to ones self a form of madness
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:30 - 246 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529201 - in reply to msg. #529199 - splitview
fark u 2 fool ramper
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:35 - 242 reads
Posted by trade4profit
IP 144.139.xxx.xxx
Post #529204 - in reply to msg. #529197 - splitview
diatribe...
Here are the posts you refer to "6 - 8 weeks ago"...
---
Subject copper strike.. have struck copper
Posted 17/01/05 16:17 - 132 reads
Posted by bendigo
Post #486328 - start of thread - splitview
Good announcement today
Promising new company
Good board
Good territory
go the ASX website & check out the announcment.
Cheers
Bendigo
---
Subject re: copper strike.. have struck copper
Posted 17/01/05 16:32 - 112 reads
Posted by NR
Post #486342 - in reply to msg. #486328 - splitview
all ready on them bendigo......awaiting further annonucements.......
---
Subject re: copper strike.. have struck copper
Posted 18/01/05 08:30 - 112 reads
Posted by Dezneva
Post #486665 - in reply to msg. #486328 - splitview
Yep, I agree. I know the people as well. They have a whole heap of old TEC ground. Its a great hit. and I think they are continuing the drilling.
---
These were the first 3 posts ever on CSE.
Although Dezneva only posted "...I know the people as well...", I can see how you may have remebered that as "...the boss being a good bloke..."
Problem is, it was Bendigo he was replying to and not you!
How do you explain that?
Cheers!
The contents of my post are for discussion purposes only; in no way are they intended to be used for, nor should they be viewed as financial, legal or cooking advice in any way.
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:40 - 234 reads
Posted by Rocker
IP 220.253.xxx.xxx
Post #529215 - in reply to msg. #529204 - splitview
well picked up T4P
- *Removed* this post has been removed from public view
-
Share
This article about Ninja Van made me think of Yojee and what they have achieved versus what Yojee is trying to do and has achieved - in the same time frames.
https://www.cnbc.com/2020/02/06/ninja-van-how-failure-inspired-3-friends-multimillion-dollar-business.html
- *Removed* this post has been removed from public view
-
ShareI get your drift joewolf.
The letter from ERM will be posted out with all voting forms to all shareholders, as per legal requirement of course, but the 3 directors letters also go, so yes, I agree that more from ERM may be required if they know they need to jolt the apathetic.
Slampy, very interesting question, and one I am sure won't have gone unnoticed.
Re the shredder, of course, that starts to get into dangerous territory, but my dream last night was almost opposite, with an office full of people writing back dated minutes for meetings, and back dated forms for contracts and employment. It was a hectic dream, and I hope there's no reality in it at all.
- *Removed* this post has been removed from public view
-
ShareAt this time of day, too many have run and will be sold off, so I look for one that's likely to run on Monday.
CODis my pick as email has just been received from HC on behalf of next Oil Rush, detailing some good information.
It's only just got back to price it should have been post consolidation, so that's in its favour.
Very little to sell, I like that, as it will move quickly.
Many won't have received the email yet as they're at work, etc.
Read more here.
http://www.nextoilrush.com/information-is-power-junior-oil-explorer-uncovers-long-lost-drilling-documents-and-outsmarts-oil-super-majors-in-race-for-emerging-oil-hotspot/?utm_source=HCMO
Looks good for next week. Be prepared!- *Removed* this post has been removed from public view
-
Sharere: it goes like this? Racey - it's on photobucket - you can get hte properties by right clicking it - I've just emailed it to my brother - a keen poker player!
Salty - howsabout an email update please imo!!- *Removed* this post has been removed from public view
-
ShareWhat a fascinating thread reading back 3 months!
Lots of reading today!
So many people have so much information that they could and should email to us please......
[email protected]
- *Removed* this post has been removed from public view
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
0.001(1.45%) |
Mkt cap ! $15.49M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.0¢ | 7.0¢ | $5.064K | 72.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28694 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 134260 | 1 |
View Market Depth
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28694 | 0.069 |
| 1 | 8500 | 0.067 |
| 1 | 119195 | 0.063 |
| 2 | 130000 | 0.062 |
| 1 | 30000 | 0.061 |
| Price($) | Vol. | No. |
|---|---|---|
| 0.079 | 134260 | 1 |
| 0.080 | 47101 | 2 |
| 0.088 | 5758 | 2 |
| 0.090 | 100100 | 2 |
| 0.091 | 948112 | 2 |
| Last trade - 10.59am 20/06/2025 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
0.001 ( 1.45 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.0¢ | 7.0¢ | 17586 | ||
| Last updated 10.59am 20/06/2025 ? | |||||
Featured News
| FRE (ASX) Chart |
The Watchlist
RML
RESOLUTION MINERALS LTD
Craig Lindsay, In-Country CEO
Craig Lindsay
In-Country CEO
SPONSORED BY The Market Online